Anthera Pharmaceuticals Inc
Anthera Pharmaceuticals Inc (ANTH) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 325 transactions totaling $25.3M, demonstrating a bearish sentiment with -$13.3M in net insider flow. The most recent transaction on Sep 20, 2017 involved a purchase of 8,550 shares valued at $11.3K.
ANTH Insider Activity Summary
Who Is Buying ANTH Stock?
No significant insider buying has been recorded for ANTH in the recent period.
Who Is Selling ANTH Stock?
No significant insider selling has been recorded for ANTH in the recent period.
Is Anthera Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ANTH is bearish with an Insider Alignment Score of 24/100 and a net flow of -$13.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ANTH Frequently Asked Questions
Understanding ANTH Insider Activity
Insider trading at Anthera Pharmaceuticals Inc (ANTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading ANTH stock, having executed 325 transactions in the past 90 days. The most active insider is Venture Partners IV Principals Fund Lp Vantagepoint (Executive), who has made 24 transactions totaling $19.3M.
Related Tools
Track Anthera Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at ANTH file new Form 4 transactions